176 related articles for article (PubMed ID: 29527805)
1. Prognostic significance of hypermethylation of death-associated protein kinase (DAPK) gene CpG island in dogs with high-grade B-cell lymphoma.
Sato M; Mochizuki H; Goto-Koshino Y; Fujiwara-Igarashi A; Takahashi M; Ohno K; Tsujimoto H
Vet Comp Oncol; 2018 Sep; 16(3):409-415. PubMed ID: 29527805
[TBL] [Abstract][Full Text] [Related]
2. Hypermethylation of the death-associated protein kinase CpG island in canine B-cell lymphoid tumors.
Sato M; Mochizuki H; Goto-Koshino Y; Fujiwara-Igarashi A; Takahashi M; Fujino Y; Ohno K; Tsujimoto H
Vet Immunol Immunopathol; 2014 Oct; 161(3-4):222-31. PubMed ID: 25193469
[TBL] [Abstract][Full Text] [Related]
3. Prognostic significance of aberrant promoter hypermethylation of CpG islands in patients with diffuse large B-cell lymphomas.
Amara K; Trimeche M; Ziadi S; Laatiri A; Hachana M; Korbi S
Ann Oncol; 2008 Oct; 19(10):1774-86. PubMed ID: 18539616
[TBL] [Abstract][Full Text] [Related]
4. Inactivation of the lamin A/C gene by CpG island promoter hypermethylation in hematologic malignancies, and its association with poor survival in nodal diffuse large B-cell lymphoma.
Agrelo R; Setien F; Espada J; Artiga MJ; Rodriguez M; Pérez-Rosado A; Sanchez-Aguilera A; Fraga MF; Piris MA; Esteller M
J Clin Oncol; 2005 Jun; 23(17):3940-7. PubMed ID: 15867203
[TBL] [Abstract][Full Text] [Related]
5. Retrospective analysis of doxorubicin and prednisone as first-line therapy for canine B-cell lymphoma.
Al-Nadaf S; Rebhun RB; Curran KM; Venable RO; Skorupski KA; Willcox JL; Burton JH
BMC Vet Res; 2018 Nov; 14(1):356. PubMed ID: 30458771
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of the prognostic significance of BCL6 gene expression in canine high-grade B-cell lymphoma.
Sato M; Kanemoto H; Kagawa Y; Kobayashi T; Goto-Koshino Y; Mochizuki H; Takahashi M; Fujino Y; Ohno K; Tsujimoto H
Vet J; 2012 Jan; 191(1):108-14. PubMed ID: 21277811
[TBL] [Abstract][Full Text] [Related]
7. Use of genome-wide DNA methylation analysis to identify prognostic CpG site markers associated with longer survival time in dogs with multicentric high-grade B-cell lymphoma.
Teoh YB; Ishizaki T; Kagawa Y; Yokoyama S; Jelinek J; Matsumoto Y; Tomiyasu H; Tsujimoto H; Takiguchi M; Yamazaki J
J Vet Intern Med; 2024; 38(1):316-325. PubMed ID: 38115210
[TBL] [Abstract][Full Text] [Related]
8. Prognostic significance of the expression levels of the p16, p15, and p14 genes in dogs with high-grade lymphoma.
Fujiwara-Igarashi A; Goto-Koshino Y; Sato M; Maeda S; Igarashi H; Takahashi M; Fujino Y; Ohno K; Tsujimoto H
Vet J; 2014 Feb; 199(2):236-44. PubMed ID: 24365070
[TBL] [Abstract][Full Text] [Related]
9. TP53 hotspot mutations are predictive of survival in primary central nervous system lymphoma patients treated with combination chemotherapy.
Munch-Petersen HD; Asmar F; Dimopoulos K; Areškevičiūtė A; Brown P; Girkov MS; Pedersen A; Sjö LD; Heegaard S; Broholm H; Kristensen LS; Ralfkiaer E; Grønbæk K
Acta Neuropathol Commun; 2016 Apr; 4():40. PubMed ID: 27101868
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of DNA methylation profiles of the CpG island of the ABCB1 gene in dogs with lymphoma.
Tomiyasu H; Fujiwara-Igarashi A; Goto-Koshino Y; Fujino Y; Ohno K; Tsujimoto H
Am J Vet Res; 2014 Sep; 75(9):835-41. PubMed ID: 25157887
[TBL] [Abstract][Full Text] [Related]
11. Effect of DNMT3A polymorphisms on CpG island hypermethylation in gastric mucosa.
Takano H; Shibata T; Nakamura M; Sakurai N; Hayashi T; Ota M; Nomura-Horita T; Hayashi R; Shimasaki T; Otsuka T; Tahara T; Arisawa T
BMC Med Genet; 2020 Oct; 21(1):205. PubMed ID: 33066747
[TBL] [Abstract][Full Text] [Related]
12. Prognostic value of baseline absolute lymphocyte concentration and neutrophil/lymphocyte ratio in dogs with newly diagnosed multi-centric lymphoma.
Mutz M; Boudreaux B; Kearney M; Stroda K; Gaunt S; Shiomitsu K
Vet Comp Oncol; 2015 Dec; 13(4):337-47. PubMed ID: 23786518
[TBL] [Abstract][Full Text] [Related]
13. Prognostic significance of Ki67 evaluated by flow cytometry in dogs with high-grade B-cell lymphoma.
Poggi A; Miniscalco B; Morello E; Gattino F; Delaude A; Ferrero Poschetto L; Aresu L; Gelain ME; Martini V; Comazzi S; Riondato F
Vet Comp Oncol; 2017 Jun; 15(2):431-440. PubMed ID: 26792094
[TBL] [Abstract][Full Text] [Related]
14. Promoter hypermethylation of the DNA-repair gene O6-methylguanine-DNA methyltransferase and p53 mutation in diffuse large B-cell lymphoma.
Hiraga J; Kinoshita T; Ohno T; Mori N; Ohashi H; Fukami S; Noda A; Ichikawa A; Naoe T
Int J Hematol; 2006 Oct; 84(3):248-55. PubMed ID: 17050200
[TBL] [Abstract][Full Text] [Related]
15. [Hypermethylation of DAP-kinase gene CpG Island in malignant lymphoma with B-cell phenotype].
Nakatsuka S; Takakuwa T; Aozasa K
Rinsho Byori; 2001 Dec; 49(12):1242-7. PubMed ID: 11797395
[TBL] [Abstract][Full Text] [Related]
16. Clinical significance of DAPK promoter hypermethylation in lung cancer: a meta-analysis.
Li Y; Zhu M; Zhang X; Cheng D; Ma X
Drug Des Devel Ther; 2015; 9():1785-96. PubMed ID: 25848215
[TBL] [Abstract][Full Text] [Related]
17. Aberrant p15, p16, p53, and DAPK Gene Methylation in Myelomagenesis: Clinical and Prognostic Implications.
Geraldes C; Gonçalves AC; Cortesão E; Pereira MI; Roque A; Paiva A; Ribeiro L; Nascimento-Costa JM; Sarmento-Ribeiro AB
Clin Lymphoma Myeloma Leuk; 2016 Dec; 16(12):713-720.e2. PubMed ID: 27622827
[TBL] [Abstract][Full Text] [Related]
18. Clinicopathological significance of DAPK gene promoter hypermethylation in non-small cell lung cancer: A meta-analysis.
Chen Z; Fan Y; Liu X; Shang X; Qi K; Zhang S
Int J Biol Markers; 2022 Mar; 37(1):47-57. PubMed ID: 34935548
[TBL] [Abstract][Full Text] [Related]
19. Hypermethylation of DAPK1 is an independent prognostic factor predicting survival in diffuse large B-cell lymphoma.
Kristensen LS; Asmar F; Dimopoulos K; Nygaard MK; Aslan D; Hansen JW; Ralfkiaer E; Grønbæk K
Oncotarget; 2014 Oct; 5(20):9798-810. PubMed ID: 25229255
[TBL] [Abstract][Full Text] [Related]
20. Promoter hypermethylation profile of kidney cancer with new proapoptotic p53 target genes and clinical implications.
Christoph F; Weikert S; Kempkensteffen C; Krause H; Schostak M; Köllermann J; Miller K; Schrader M
Clin Cancer Res; 2006 Sep; 12(17):5040-6. PubMed ID: 16951219
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
